MedPath

APO-DEXLANSOPRAZOLE

APO-DEXLANSOPRAZOLE

Approved
DIN Number

02528991

Drug Class

Human

Market Date

Feb 26, 2024

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02528991
AIG Number0152766001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BC06 DEXLANSOPRAZOLE
Product Specifications
Dosage FormCapsule (Delayed Release)
Route of AdministrationNasogastric ,  Oral
AHFS Classification56:28.36
Health Canada Classification

ACTIVE INGREDIENTS (1)

DEXLANSOPRAZOLEActive
Strength: 30 MG
Monograph: DEXLANSOPRAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.